Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys
- 19 November 2009
- journal article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 23 (10) , 877-882
Abstract
[18F]Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) is a useful tool for measuring the regional cerebral metabolic rate of glucose (rCMRglu), which is an index of neuronal activity. Donepezil, an acetylcholine esterase inhibitor (AChEI), has been recommended as a treatment option for patients with Alzheimer’s disease (AD). We aimed to characterize the effects of donepezil on rCMRglu using FDG-PET in non-human primates. We investigated the effects of administration of donepezil (500 μg/kg, i.m.), the non-selective muscarinic ACh receptor antagonist scopolamine (30 μg/kg, i.m.), and the coadministration of both drugs on the rCMRglu of conscious young rhesus monkeys. Donepezil increased the rCMRglu in all regions of interest except in the thalamus. Scopolamine treatment also increased the rCMRglu in all regions of interest except the cerebellum and thalamus. However, these effects disappeared with coadministration of the drugs. This PET study showed that administration of donepezil or scopolamine alone increased the rCMRglu in conscious rhesus monkeys. We also found that the donepezil-induced increase was abolished by simultaneous administration of scopolamine, suggesting that muscarinic ACh receptor function plays an important role in the effect of donepezil.Keywords
This publication has 23 references indexed in Scilit:
- Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humansPharmacology Biochemistry and Behavior, 2005
- Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s diseaseJournal of Neural Transmission, 2005
- Pilocarpine prevents age-related spatial learning impairments in ratsBehavioural Brain Research, 2005
- A multinational, randomised, 12‐week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2004
- Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s DiseaseDrugs & Aging, 2004
- The Scopolamine-Induced Impairment of Spatial Cognition Parallels the Acetylcholine Release in the Ventral Hippocampus in RatsThe Japanese Journal of Pharmacology, 2000
- A high resolution animal PET scanner using compact PS-PMT detectorsIEEE Transactions on Nuclear Science, 1997
- Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]DeoxyglucoseJournal of Cerebral Blood Flow & Metabolism, 1985
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of methodAnnals of Neurology, 1979
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977